• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Immunol Res . Induction of Humoral and Cellular Immunity by Intradermal Delivery of SARS-CoV-2 Nucleocapsid Protein Using Dissolvable Microneedles

tetano

Editor, Senior Moderator
J Immunol Res


. 2021 May 17;2021:5531220.
doi: 10.1155/2021/5531220. eCollection 2021.
Induction of Humoral and Cellular Immunity by Intradermal Delivery of SARS-CoV-2 Nucleocapsid Protein Using Dissolvable Microneedles


Chaiyaporn Kuwentrai[SUP] 1 [/SUP], Jinming Yu[SUP] 2 [/SUP], Bao-Zhong Zhang[SUP] 3 [/SUP], Ye-Fan Hu[SUP] 1 4 [/SUP], Ying Dou[SUP] 1 [/SUP], Hua-Rui Gong[SUP] 1 [/SUP], Jian-Dong Huang[SUP] 1 3 [/SUP], Chenjie Xu[SUP] 2 [/SUP]



Affiliations
Free PMC article

Abstract

The nucleocapsid protein (NP) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contains immunogenic epitopes that can induce cytotoxic T lymphocyte (CTL) against viral infection. This makes the nucleocapsid protein a suitable candidate for developing a vaccine against SARS-CoV-2 infection. This article reports the intradermal delivery of NP antigen using dissolvable microneedle skin patches that could induce both significant B cell and T cell responses.
 
Back
Top Bottom